1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-025

PAR-25-025National Institutes of HealthR33

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Deadline
Award ceiling
$1,515,000
Awards
Not stated
Posted
Dec 5, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

The objective of this Notice of Funding Opportunity (NOFO) is to support investigator-initiated, Phase 1 clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multi-site…

Related NIH announcements4

Companion announcements with the same title first, then other open R33 announcements on related subjects with at least two weeks to go.

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria

No card required. Browsing is free.

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cardiovascular, Respiratory), with at least two weeks to apply.

Everything open tagged Cardiovascular

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-025.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.